Archiv der Pharmazie · 2019 · 28 citations · 37 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyLigand BindingLigand-based DesignMolecular DockingProtein DockingProtein-ligand DockingTyrosine Kinase InhibitorsAdme ProfilingAlignment StudiesAnticancer ActivityDocking-based Drug DesignMolecular Docking AnalysisMolecular Docking Of InhibitorsTyrosine Kinase InhibitionTyrosine Kinase Receptors
The present research focused on designing a quinazoline skeleton, framed via 1,3,5-triazine derivatives (QBT) through field mapping and alignment studies. The QBT derivatives were synthesized via time- and cost-effective protocol. The 3D-QSAR study, computational physicochemical properties, and ADME calculation of the derivatives were performed to establish the affinity towards the biological system. Molecular docking in the adenosine triphosphate binding site of the RET tyrosine kinase domain (PDB ID: 7IVU) was studied to elucidate vital structural residues necessary for bioactivity. The derivatives were evaluated for anticancer potency against TPC-1 cells (thyroid cancer), MCF-7 cells (breast cancer), and one normal cell line (human foreskin fibroblasts) via 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide assay followed by an in ovo CAM assay. The entire series of derivatives (8a-o) showed mild to significant anticancer potency against the selected cancer cell lines.
37
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita, Seung‐Yeol Park, Tadashi Nishio et al. · Scientific Reports · 2017 · 16.1K citations · Full text
Quinazoline derivatives: synthesis and bioactivities
Dan Wang, Feng Gao · Chemistry Central Journal · 2013 · 195 citations · Full text